HEAD-TO-HEAD

ARGIRELINE VS MATRIXYL-3000

The two canonical cosmetic peptides target different wrinkle types via different mechanisms. Argireline (acetyl hexapeptide-8) is a SNAP-25 mimic that blocks SNARE-complex assembly at the neuromuscular junction, reducing dynamic expression-line wrinkles. Matrixyl-3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) is a matrikine peptide blend that drives fibroblast collagen and glycosaminoglycan synthesis, addressing static wrinkles from extracellular matrix loss. The two are complementary and commonly combined in cosmetic formulations.

A · No. 042HP 85

ARGIRELINE

Acetyl Hexapeptide-8 · SNAP-25 Fragment

B · No. 043HP 90

MATRIXYL-3000

Matrikine Peptide Blend · Collagen Inducer

SIDE BY SIDE

FIELD

A · ARGIRELINE

B · MATRIXYL-3000

Class

Single synthetic hexapeptide · SNAP-25 mimic

Two-peptide matrikine blend (pal-GHK + pal-GQPR)

Sequence

Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2

Palmitoyl-Gly-His-Lys + Palmitoyl-Gly-Gln-Pro-Arg

Mechanism

SNARE-complex inhibition · reduces acetylcholine release at NMJ

Matrikine signaling · upregulates collagen / elastin / GAG synthesis

Wrinkle type targeted

Dynamic expression-line wrinkles

Static wrinkles · extracellular matrix loss

Typical cosmetic concentration

5-10%

3-8%

Best published evidence

Blanes-Mira 2002 · 30% wrinkle-depth reduction at 28 days

Robinson 2005 · palmitoyl pentapeptide topical improves photoaged skin

Time to visible effect

~28 days (twice daily)

~8-12 weeks (twice daily, collagen turnover is slower)

Route

Topical (cosmetic)

WHICH IS BETTER · BY GOAL

▶ Crow's feet / forehead expression linesA · ARGIRELINE

Dynamic wrinkles driven by repeated muscle contraction respond to Argireline's SNARE-complex inhibition.

▶ Skin firmness / fine static wrinklesB · MATRIXYL-3000

Static wrinkles from extracellular matrix loss respond to Matrixyl-3000's collagen-induction signaling.

▶ Speed to visible resultA · ARGIRELINE

Argireline produces measurable effect at 28 days. Matrixyl-3000 effects emerge at 8-12 weeks because new collagen synthesis is slower.

▶ Long-term skin-aging researchB · MATRIXYL-3000

Stimulating new extracellular matrix synthesis addresses the underlying skin-aging process. Argireline only suppresses muscle contractions.

▶ Botox-style cosmetic mechanism analogA · ARGIRELINE

Argireline and Botox target the same SNARE complex. Matrixyl-3000 is not a Botox-mechanism analog.

STACKING NOTE

Argireline + Matrixyl-3000 is the canonical topical cosmetic peptide stack. The two mechanisms are complementary (dynamic + static wrinkle reduction). Many commercial cosmetic formulations include both. No published RCT validates the specific combination, but the mechanistic complementarity is the basis for routine co-formulation.

SOURCED FROM PEPPU LABS

Both compounds are available as research-grade material at Peppu Studio · ≥99% purity · per-batch CoA. For laboratory research use only.

SOURCE ARGIRELINE ▶SOURCE MATRIXYL-3000 ▶